160 related articles for article (PubMed ID: 21192531)
1. A new shine on an old med. The story of metformin's past, present, and possible future.
Gebel E
Diabetes Forecast; 2010 Dec; 63(12):48-51. PubMed ID: 21192531
[No Abstract] [Full Text] [Related]
2. The link between polycystic ovarian syndrome and type 2 diabetes: preventive and therapeutic approach in Israel.
Jakubowicz D; Wainstein J; Homburg R
Isr Med Assoc J; 2012 Jul; 14(7):442-7. PubMed ID: 22953622
[No Abstract] [Full Text] [Related]
3. Role of metformin in patients with polycystic ovary syndrome: the state of the art.
Palomba S; Falbo A; Russo T; Orio F; Tollino A; Zullo F
Minerva Ginecol; 2008 Feb; 60(1):77-82. PubMed ID: 18277354
[TBL] [Abstract][Full Text] [Related]
4. Use of metformin in pediatric age.
Brufani C; Fintini D; Nobili V; Patera PI; Cappa M; Brufani M
Pediatr Diabetes; 2011 Sep; 12(6):580-8. PubMed ID: 21366813
[No Abstract] [Full Text] [Related]
5. Metformin in polycystic ovary syndrome.
Fisken RA
N Engl J Med; 2008 Apr; 358(17):1866-7; author reply 1868. PubMed ID: 18437727
[No Abstract] [Full Text] [Related]
6. Metformin use and diabetic pregnancy-has its time come?
Hawthorne G
Diabet Med; 2006 Mar; 23(3):223-7. PubMed ID: 16492202
[TBL] [Abstract][Full Text] [Related]
7. Use of insulin sensitizing agents in the treatment of polycystic ovary syndrome.
Practice Committee of the American Society for Reproductive Medicine
Fertil Steril; 2006 Nov; 86(5 Suppl 1):S221-3. PubMed ID: 17055827
[No Abstract] [Full Text] [Related]
8. Insulin-sensitizing agents in women with polycystic ovary syndrome.
Pasquali R; Gambineri A
Fertil Steril; 2006 Jul; 86 Suppl 1():S28-9. PubMed ID: 16798283
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and metformin in polycystic ovary syndrome.
Ben-Haroush A; Yogev Y; Fisch B
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):125-33. PubMed ID: 15262344
[TBL] [Abstract][Full Text] [Related]
10. 'Off-label' use of metformin warranted.
Robinson K
Adv Nurse Pract; 2001 Mar; 9(3):21. PubMed ID: 12400319
[No Abstract] [Full Text] [Related]
11. Metformin therapy and diabetes in pregnancy.
Simmons D; Walters BN; Rowan JA; McIntyre HD
Med J Aust; 2004 May; 180(9):462-4. PubMed ID: 15115425
[TBL] [Abstract][Full Text] [Related]
12. Metformin use in polycystic ovary syndrome: metabolic benefits and diabetes prevention.
Goodarzi MO; Azziz R
Am J Med; 2008 Aug; 121(8):e9; author reply e11. PubMed ID: 18691471
[No Abstract] [Full Text] [Related]
13. [Insulin sensitizers in the treatment of polycystic ovary].
Ortiz Núñez DA; Hernández Marín I; Ayala AR
Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
[TBL] [Abstract][Full Text] [Related]
14. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
Glueck CJ; Goldenberg N; Sieve L; Wang P
Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
[TBL] [Abstract][Full Text] [Related]
15. [Metformin for the treatment of polycystic ovary syndrome].
Pekhlivanov B; Mitkov M
Akush Ginekol (Sofiia); 2005; 44(4):37-41. PubMed ID: 16028378
[No Abstract] [Full Text] [Related]
16. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.
Diamanti-Kandarakis E; Christakou CD; Kandaraki E; Economou FN
Eur J Endocrinol; 2010 Feb; 162(2):193-212. PubMed ID: 19841045
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome.
Ehrmann DA
N Engl J Med; 2005 Mar; 352(12):1223-36. PubMed ID: 15788499
[No Abstract] [Full Text] [Related]
18. Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update.
Katsiki N; Hatzitolios AI
Curr Opin Obstet Gynecol; 2010 Dec; 22(6):466-76. PubMed ID: 20724929
[TBL] [Abstract][Full Text] [Related]
19. [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
Vrbíková J; Hill M; Stárka L; Cibula D; Snajderová M; Sulcová J; Vondra K; Bendlová B
Cas Lek Cesk; 2001 Nov; 140(22):688-94. PubMed ID: 11789058
[TBL] [Abstract][Full Text] [Related]
20. Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance.
Topcu S; Tok D; Caliskan M; Ozcimen EE; Gullu H; Uckuyu A; Erdogan D; Zeyneloglu H; Muderrisoglu H
Clin Endocrinol (Oxf); 2006 Jul; 65(1):75-80. PubMed ID: 16817823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
